ArticleFrontiers in oncology2022

FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells.

Huayuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.